Clinical Trial

Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Study acronym: OLFGBM
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to investigate the prognostic significance of olfactory function in patients with glioblastoma. We are examining olfactory function at various points during therapy and correlating the results with survival data. In addition, neurocognitive tests will be carried out to correlate the results of olfactory function with the patient's cognitive abilities. Investigations into the quality of life and psychological condition of the patients are also performed. In addition to the cohort of glioblastoma patients, there is a control cohort without tumor disease in which the olfactory testing is also carried out in order to have a comparison.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-24; most recent amendment 2025-07-02.
Trial Details
NCT Number NCT06954636
Lead Sponsor Sied Kebir
Collaborators: Münster University Hospital, Germany
Conditions Glioblastoma Multiforme, Adult, Glioblastoma or Gliosarcoma, Glioblastoma, Adult
Enrollment 128 participants
Start Date 2023-05-03
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-07-08